Odds ratios for confirmed markers of transfusion-transmitted infectious diseases in blood and its component donations in Lithuania: A comparison between pandemic years. by Vytenis Kalibatas (14123877)

Odds ratios for confirmed transfusion-transmitted infectious disease markers in blood and its components’ donations: Comparison the pre-pandemic year with the pandemic years. by Vytenis Kalibatas (14123877)

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

Pooled odds ratios for mortality when peak > 15mL/kg/min. by Nabeela Arbee-Kalidas (17598969)

Subjects:

Pooled odds ratios for morbidity when peak > 15mL/kg/min. by Nabeela Arbee-Kalidas (17598969)

Subjects:

The odds of death affected by immune cells in patients with COVID-19. by Sam Alahyari (12645313)

Sobel test for the significance of the mediation effect. by Getachew Magnar Kitila (19935139)

Posterior, mid-posterior, central, and mid-anterior corpus callosal volume significantly decreased with increasing risk of environmental lead exposure. by Andrew T. Marshall (10159199)

Significant variables of DR association from univariate analyses. by Radhika Krishnan (15213756)

Odds ratios for each case period compared with the control period. by Rieko Kondo (10010647)

Subjects:

Craniocaudal impulses of fore- and hindlimbs at three bar heights during take-off. by Leena Inkilä (20614460)

Fig 4 - by Leena Inkilä (20614460)

Adjusted and unadjusted odds ratios for mortality with fluid administration. by Brian Rice (4393609)

Subjects:

Pathway associated with decreased inflammation. by Monica N. Mweetwa (17054522)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

Table_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_3_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Table_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”